Endocrine System Diseases  >>  GEM 640  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GEM 640 / Pharmascience
NCT00557596 / 2007-005961-36: A Phase 1-2, XIAP Antisense AEG35156 With Gemcitabine in Patients With Advanced Pancreatic Cancer

Terminated
1/2
48
US
AEG35156
Aegera Therapeutics
Carcinoma, Pancreas
11/09
11/09

Download Options